The Influence of Cyclosporin on Cytomegalovirus-Related Kidney Graft Survival

In 1981, we reported that one-year actuarial kidney graft survival was much better in recipients with no evidence of cytomegalovirus (CMV) infection than in recipients with primary CMV infection (1). At that time standard post-transplant therapy consisted of prednisone and azathioprine. Four-and-a-half-years ago azathioprine was replaced with cyclosporin. The present paper concerns graft survival in relation to CMV in these patients.